Notifiable Disease Incidence in New York State

October 14, 2026
New York State Communicable Diseases Epidemiology Data Visualization


Published: June 13, 2023
Updated: October 14, 2026 at 05:51PM


Welcome

Welcome to my personal data science website, where I focus on epidemiology and public health. On this page, I present data analyses on communicable disease incidence in New York State. The data used in these analyses are obtained from the Centers for Disease Control and Prevention (CDC) through the data.CDC.gov open data platform. The latest data are provisional and subject to updates.

I updated this page on a weekly basis.

Data Overview

The data presented on this page are weekly cases of selected infectious national notifiable diseases in the United States, including New York State. These cases are reported to the National Notifiable Diseases Surveillance System (NNDSS). The NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables by the CDC.

It’s important to note that the case counts listed in the tables are provisional and may change as additional information becomes available. State health departments report cases to the CDC for weekly publication, and ongoing revisions and delayed reporting can impact the numbers listed in later weeks. For a comprehensive understanding of interpreting these data, please refer to the Guide to Interpreting Provisional and Finalized NNDSS Data.

How to Use These Data

The summary data are now presented in a comprehensive table format with the following columns: * Disease: The name of the notifiable disease. * First MMWR Week with Any Cases Reported: The earliest week of the year when any cases were reported. * Latest MMWR Week with Any Cases Reported: The most recent week with reported cases. * Current Week Reported Cases: The number of cases reported for the current week. * Cumulative Reported Cases: The total number of cases reported so far for the year. * Trend: A sparkline visualization summarizing the weekly longitudinal trends in reported cases.

This table provides an at-a-glance overview of disease incidence, highlighting patterns over time and identifying changes in reporting. The trend column’s sparklines enable quick visual assessments of fluctuations or seasonality in disease activity.

The longitudinal trend graphs, displayed as line graphs, show the incidence of each disease over time. Each disease is represented by a separate line on the graph, allowing you to observe changes in disease occurrence and identify any seasonal patterns or long-term trends.

Why Are These Data Important?

These data play a crucial role in monitoring and understanding communicable diseases in New York State. By tracking the incidence of notifiable diseases, public health officials can identify outbreaks, assess the impact of interventions, and allocate resources effectively. These data inform public health policies and interventions aimed at preventing and controlling the spread of infectious diseases.

What Do These Data Show?

The table and graphs together provide a comprehensive view of the temporal and cumulative patterns of disease incidence: * First and Latest Weeks with Cases: These columns in the table help identify the duration of disease activity over the year. * Current Week Reported Cases: This column offers a snapshot of the most recent case data. * Cumulative Cases: This total highlights the overall burden of each disease. * Trend (Sparklines): The sparkline visualizations in the table illustrate how the weekly incidence has varied, revealing potential patterns, seasonality, or anomalies. * Longitudinal Trend Graphs: These graphs provide a detailed visualization of weekly case trends for each disease, allowing for a deeper understanding of changes over time and enabling the identification of specific weeks with spikes or declines.

What Do These Data Not Show?

While these data provide valuable information on the incidence of notifiable diseases, it’s important to note their limitations. The data only include cases that are reported to the CDC and may not capture the complete picture of disease incidence in New York State. Some cases may go unreported or may not meet the criteria for being included in the notifiable diseases list.

Additionally, the data are provisional and subject to updates. As more information becomes available and reporting is finalized, the case counts may change. Therefore, it’s crucial to interpret these data with caution and consider them as a snapshot of disease incidence at a specific point in time.

Implications for Public Health Practice

These data have significant implications for public health practice in New York State. By analyzing the trends and patterns in disease incidence, public health professionals can identify priority areas for intervention, allocate resources effectively, and develop targeted strategies to prevent and control communicable diseases. The insights gained from these data can inform decision-making, guide surveillance efforts, and contribute to evidence-based public health policies.

Thank you for visiting my website and exploring the data analyses on communicable disease incidence in New York State. I hope these insights contribute to your understanding of the public health landscape and support efforts to improve population health.


Executive Summary1

Surveillance data for the week starting October 4, 2026, show that sexually transmitted infections and enteric diseases drove the highest incidence in New York State. Chlamydia trachomatis infection recorded the highest burden with 1,391 cases, a 14.5% decrease from the previous week. Gonorrhea followed with 632 cases, a 4.8% decline. Conversely, campylobacteriosis ranked third, climbing 22.9% to 177 reported cases.

The data highlight a notable uptick in indigenous measles, reaching 30 cases. This represents an increase of 12 cases (66.7%) from the prior week and a 233.3% rise over the past four weeks, which may reflect expanding localized transmission or pockets of diminished vaccine coverage.

Additionally, confirmed invasive pneumococcal disease (all ages) rose to 35 cases, a 66.7% weekly increase. Pertussis cases also doubled from 5 to 10. These concurrent increases could suggest an early start to the seasonal respiratory pathogen cycle. Continuous monitoring of these patterns remains essential.



Summary Table

Notifiable Diseases in New York State, 2022 to Present
Disease
MMWR Weeks with Any Cases Reported
Reported Cases
Trend
First Week Latest Week Current Week Cumulative
Chlamydia trachomatis infection 2022-01-02 2026-10-04 1,391 253,526 1.4K
Gonorrhea 2022-01-02 2026-10-04 632 96,344 632.0
Campylobacteriosis 2022-01-02 2026-10-04 177 29,881 177.0
Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection) 2022-01-02 2026-10-04 100 14,849 100.0
Hepatitis B, chronic, Confirmed 2023-12-31 2026-09-13 0 13,093 0.00
Shigellosis 2022-01-02 2026-10-04 48 11,378 48.0
Giardiasis 2022-01-02 2026-10-04 43 10,264 43.0
Hepatitis C, chronic, Probable 2023-12-31 2026-09-13 0 6,830 0.00
Invasive pneumococcal disease, all ages, Confirmed 2022-01-02 2026-10-04 35 6,801 35.0
Hepatitis C, chronic, Confirmed 2023-12-31 2026-08-16 0 6,645 0.00
Shiga toxin-producing Escherichia coli (STEC) 2022-01-02 2026-10-04 50 5,175 50.0
Syphilis, Primary and secondary 2022-01-02 2026-10-04 26 4,361 26.0
Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection 2022-01-02 2023-12-24 NA 3,346 0.00
Pertussis 2022-01-16 2026-10-04 10 3,209 10.0
Tuberculosis 2022-01-02 2026-10-04 11 3,085 11.0
Legionellosis 2022-01-02 2026-10-04 20 2,611 20.0
Hepatitis B, chronic, Probable 2024-03-10 2026-08-16 0 2,422 0.00
Babesiosis 2022-01-30 2024-12-22 NA 2,292 0.0
Cryptosporidiosis 2022-01-02 2026-10-04 11 2,168 11.0
Haemophilus influenzae, invasive disease, All ages, all serotypes 2022-01-02 2026-10-04 7 1,846 7.0
Cyclosporiasis 2022-02-20 2026-10-04 2 1,462 2.0
Vibriosis (any species of the family Vibrionaceae, other than toxigenic Vibrio cholerae O1 or O139), Probable 2022-02-20 2026-10-04 7 695 7.0
Hepatitis C, acute, Confirmed 2022-03-27 2026-08-16 0 613 0.0
Mpox 2023-12-31 2026-10-04 4 579 4.00
Invasive pneumococcal disease, all ages, Probable 2022-01-02 2026-10-04 1 415 1.0
Listeriosis, Confirmed 2022-01-02 2026-10-04 3 373 3.0
Ehrlichiosis and Anaplasmosis, Ehrlichia chaffeensis infection 2022-01-02 2023-12-10 NA 356 0.00
Malaria 2022-01-23 2026-09-27 0 322 0.0
Vibriosis (any species of the family Vibrionaceae, other than toxigenic Vibrio cholerae O1 or O139), Confirmed 2022-01-02 2026-10-04 2 217 2.00
Invasive pneumococcal disease, age <5 years, Confirmed 2022-01-02 2026-10-04 1 202 1.0
Hepatitis A, Confirmed 2023-11-05 2026-10-04 1 189 1.00
Rabies, Animal 2022-01-02 2022-12-18 NA 187 0.00
Hepatitis B, acute, Confirmed 2024-01-07 2026-08-16 0 176 0.00
Meningococcal disease, All serogroups 2022-01-02 2026-09-20 0 171 0.00
Meningococcal disease, Unknown serogroup 2022-01-02 2026-09-20 0 159 0.00
Hepatitis, A, acute 2022-01-02 2023-12-17 NA 146 0.00
Measles, Indigenous 2025-11-23 2026-10-04 30 136 30.00
Dengue virus infections, Dengue 2022-08-28 2026-10-04 1 119 1.00
Haemophilus influenzae, invasive disease, Age <5 years, Unknown serotype 2022-02-13 2026-10-04 1 102 1.00
Streptococcal toxic shock syndrome 2022-01-30 2026-10-04 2 101 2.00
Salmonella Typhi infection 2022-02-27 2026-10-04 1 94 1.00
Hepatitis, B, acute 2022-01-02 2023-11-26 NA 82 0.00
Hepatitis C, acute, Probable 2022-01-02 2026-07-26 0 68 0.00
Arboviral diseases, West Nile virus disease 2022-07-31 2026-10-04 2 66 2.00
Listeriosis, Probable 2022-01-09 2026-09-20 0 54 0.00
Mumps 2022-01-30 2026-09-13 0 43 0.00
Influenza-associated pediatric mortality 2022-06-12 2026-02-22 0 33 0.00
Leptospirosis 2023-07-30 2026-09-20 0 28 0.00
Hepatitis B, acute, Probable 2024-03-17 2026-08-16 0 27 0.00
Q fever, Total 2022-05-01 2026-08-30 0 25 0.00
Tularemia 2022-11-06 2026-08-23 0 25 0.00
Vancomycin-intermediate Staphylococcus aureus 2022-02-13 2026-06-28 0 23 0.00
Brucellosis 2022-06-12 2026-08-16 0 20 0.00
Q fever, Acute 2022-05-01 2026-08-30 0 19 0.00
Salmonella Paratyphi infection 2022-08-28 2026-09-20 0 19 0.00
Invasive pneumococcal disease, age <5 years, Probable 2022-11-27 2026-10-04 1 15 1.00
Arboviral diseases, Chikungunya virus disease 2022-10-09 2026-09-27 0 14 0.00
Measles, Imported 2024-03-24 2026-06-07 0 14 0.00
Ehrlichiosis and Anaplasmosis, Undetermined ehrlichiosis/anaplasmosis 2022-06-05 2023-12-03 NA 13 0.00
Haemophilus influenzae, invasive disease, Age <5 years, Serotype b 2022-01-30 2026-07-19 0 12 0.00
Hepatitis C, perinatal infection 2022-03-06 2023-11-12 NA 11 0.00
Hemolytic uremic syndrome post-diarrheal 2023-05-14 2026-08-16 0 10 0.00
SalmonellaParatyphi infection 2025-02-23 2026-02-15 NA 10 0.00
Toxic shock syndrome (other than Streptococcal) 2022-03-13 2026-07-19 0 10 0.00
Arboviral diseases, Powassan virus disease 2022-10-02 2026-10-04 1 9 1.00
Haemophilus influenzae, invasive disease, Age <5 years, Nontypeable 2022-05-15 2026-01-18 0 9 0.00
Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype 2022-01-23 2026-05-03 0 8 0.00
Meningococcal disease, Serogroup B 2022-03-20 2025-11-23 0 6 0.00
Q fever, Chronic 2023-02-12 2024-11-17 0 6 0.00
Botulism, Infant 2023-02-05 2025-11-09 0 5 0.00
Hansen's disease 2022-10-30 2024-12-22 NA 4 0.00
Hepatitis C, perinatal, Confirmed 2023-11-12 2024-12-15 0 4 0.00
Meningococcal disease, Serogroups ACWY 2023-04-02 2025-04-13 0 4 0.00
Arboviral diseases, Eastern equine encephalitis virus disease 2024-09-22 2025-09-21 0 3 0.00
Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection 2022-07-24 2023-12-17 NA 3 0.00
Hepatitis B, acute 2023-11-05 2023-11-26 NA 3 0.00
Hepatitis B, perinatal, Confirmed 2025-05-11 2026-06-21 0 3 0.00
Leprosy (Hansen's disease) 2026-03-22 2026-07-05 0 3 0.00
Tetanus 2023-11-19 2026-08-23 0 3 0.00
Carbapenemase-Producing Organisms (CPO), Total 2026-08-23 2026-08-23 0 2 0.00
Meningococcal disease, Other serogroups 2026-03-22 2026-09-20 0 2 0.00
Botulism, Foodborne 2025-08-31 2025-08-31 0 1 0.00
Botulism, Other (wound & unspecified) 2023-03-05 2023-03-05 0 1 0.00
Chancroid 2022-04-03 2022-04-03 0 1 0.00
Hantavirus pulmonary syndrome 2026-03-08 2026-03-08 0 1 0.00
Hepatitis B, perinatal infection 2022-10-30 2022-10-30 NA 1 0.00
Rubella 2023-04-09 2023-04-09 0 1 0.00
Latest MMWR Week Reported: October 04, 2026
Data as of: October 14, 2026

Table Prepared By: Isaac H. Michaels, DrPH
Data Source: U.S. Centers for Disease Control and Prevention


Back to top





  1. This executive summary was generated by an AI summarizer agent and reviewed by an editor agent. I review any summaries flagged for revision.↩︎

New York Racing Horse Death Report

October 14, 2026
New York State Animal Welfare Equine Fatality Analysis

This report utilizes data from the New York State Gaming Commission to analyze equine fatalities at race tracks, uncovering trends and patterns to enhance horse safety and welfare. Despite limitations like potential underreporting and data quality issues, the report offers critical insights into the…

Read more →

New York State Food Establishment Inspection Maps

October 14, 2026
New York State Food Safety Environmental Health Public Health GIS

Explore detailed data on food service inspections across New York State, including New York City. This page features interactive maps and tables displaying inspection results, violations, and compliance statuses for food establishments. Users can filter data by location and inspection outcome to ass…

Read more →

United States COVID-19 Data Tracking Report

October 14, 2026
United States COVID-19 Communicable Diseases Epidemiology GIS

Published: March 25, 2020 Updated: October 14, 2026 at 05:45PM Welcome Welcome to this web page, which presents analyses of data on COVID-19 in the United States. I believe that data are an essential component of any public health response. The data on this page are obtained from the data.cdc.gov op…

Read more →